You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Peginterferon

Showing 1 - 25 of 870
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Hepatitis B Trial run by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (VIR-2218 and

Not yet recruiting
  • Chronic Hepatitis B
  • VIR-2218 and peginterferon alfa-2a
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Oct 27, 2023

Chronic Hepatitis Delta Trial run by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (Peginterferon

Not yet recruiting
  • Chronic Hepatitis Delta
  • Peginterferon Lambda
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jul 25, 2023

Herpes Zoster Trial (Peginterferon a1b, Peginterferon a1b with valacyclovir, Valacyclovir)

Not yet recruiting
  • Herpes Zoster
  • Peginterferon α1b
  • +2 more
  • (no location specified)
Aug 5, 2022

Sars-CoV-2 Infection Trial in Baltimore (Peginterferon lambda alfa-1a subcutaneous injection, Saline)

Terminated
Has Results
  • Sars-CoV-2 Infection
  • Peginterferon lambda alfa-1a subcutaneous injection
  • Saline
  • Baltimore, Maryland
    Johns Hopkins Hospital
Jul 12, 2022

Sars-CoV2, Covid19 Trial in Toronto (Peginterferon Lambda-1A, Placebo)

Active, not recruiting
  • Sars-CoV2
  • Covid19
  • Peginterferon Lambda-1A
  • Placebo
  • Toronto, Ontario, Canada
    Toronto General Hospital
Apr 4, 2022

Chronic Hepatitis B Patients With a Normal ALT Level and Low Viremia Trial in Fuzhou (Peginterferon alpha-2b, Nucleotide Analog,

Recruiting
  • Chronic Hepatitis B Patients With a Normal ALT Level and Low Viremia
  • Peginterferon alpha-2b
  • +2 more
  • Fuzhou, Fujian, China
    Fuzhou General Hospital, Xiamen Univ
Jan 21, 2022

Chronic Hepatitis B, High-Risk Cancer Trial in China (Peginterferon alfa-2b Injection, Nucleos (t) ide Analogue, Nucleos(t)ide

Active, not recruiting
  • Chronic Hepatitis B
  • High-Risk Cancer
  • Peginterferon alfa-2b Injection, Nucleos (t) ide Analogue
  • Nucleos(t)ide analogue
  • Chengdu, China
  • +8 more
Jan 4, 2023

Chronic HBV Infection Trial in Shenzhen (Peginterferon alfa-2b combined and ETV)

Recruiting
  • Chronic HBV Infection
  • Peginterferon alfa-2b combined and ETV
  • Shenzhen, China
    Shenzhen Third People Hospital
Mar 19, 2023

COVID-19 Trial in Stanford (Peginterferon Lambda-1a, Placebo)

Completed
Has Results
  • COVID-19
  • Peginterferon Lambda-1a
  • Placebo
  • Stanford, California
    Stanford University School of Medicine
Nov 24, 2021

MS (Multiple Sclerosis), Erythema Trial in Kirkland (Warm Compress Before Injection, Cold Compress After Injection)

Completed
  • MS (Multiple Sclerosis)
  • Erythema
  • Warm Compress Before Injection
  • Cold Compress After Injection
  • Kirkland, Washington
    Evergreen Health
Mar 10, 2022

Membranous Nephropathy Trial in Nice (Peginterferon Alfa-2A 180 MCG/ML Injectable Solution)

Not yet recruiting
  • Membranous Nephropathy
  • Peginterferon Alfa-2A 180 MCG/ML Injectable Solution
  • Nice, France
    CHU de NICE
Jul 4, 2023

Functional Cure of Hepatitis B in HIV/HBV Co-infected Patients

Recruiting
  • AIDS
  • Hepatitis B
  • Peginterferon alfa-2b Injection
  • Guangzhou, Guangdong, China
    Guangzhou Eighth People's Hospital, Guangzhou Medical University
Aug 10, 2023

Advanced Cholangiocarcinoma Trial in Washington (Pembrolizumab, Sylatron)

Terminated
Has Results
  • Advanced Cholangiocarcinoma
  • Washington, District of Columbia
    Georgetown Lombardi Comprehensive Cancer Center
Feb 14, 2022

Healthy Subjects, Pharmacokinetics, Pharmacodynamics Trial in West Bend (Interferon beta-1a, Peginterferon beta-1a, Placebo)

Completed
  • Healthy Subjects
  • +2 more
  • Interferon beta-1a
  • +2 more
  • West Bend, Wisconsin
    Spaulding Clinical Research
Aug 16, 2021

Relapsing Remitting Multiple Sclerosis (RRMS) Trial in Tehran (Pegylated interferon beta-1a, Interferon Beta-1A Prefilled

Active, not recruiting
  • Relapsing Remitting Multiple Sclerosis (RRMS)
  • Pegylated interferon beta-1a
  • Interferon Beta-1A Prefilled Syringe
  • Tehran, Iran, Islamic Republic of
    Sina Hospital
Feb 5, 2022

Chronic Hepatitis B Trial in China (Peginterferon alfa-2b injection, TDF)

Active, not recruiting
  • Chronic Hepatitis B
  • Peginterferon alfa-2b injection
  • TDF
  • Beijing, China
  • +32 more
Jul 17, 2022

Multiple Sclerosis, Relapsing-Remitting Trial in Worldwide (Dimethyl Fumarate, Peginterferon Beta-1a, Placebo)

Terminated
  • Multiple Sclerosis, Relapsing-Remitting
  • Dimethyl Fumarate
  • +2 more
  • Raleigh, North Carolina
  • +22 more
Nov 30, 2022

Assess Pregnancy Outcomes in Women Exposed to Diroximel Fumarate

Recruiting
  • Multiple Sclerosis
  • Diroximel Fumarate
  • +8 more
  • Eden Prairie, Minnesota
    OptumInsight
Jan 9, 2023

Chronic Hepatitis B Trial (PEG IFN a-2b; TAF)

Not yet recruiting
  • Chronic Hepatitis B
  • PEG IFN α-2b; TAF
  • (no location specified)
Aug 5, 2022

Female Participants Exposed to Subcutaneous Peginterferon

Completed
  • Multiple Sclerosis
  • Multiple Sclerosis, Relapsing-Remitting
  • Interferon Beta Therapy
  • Göttingen, Germany
    Research Site
Nov 1, 2021

Sars-CoV2, Covid-19 Trial in Brazil, Canada (Peginterferon Lambda-1A, )

Recruiting
  • Sars-CoV2
  • Covid-19
  • Peginterferon Lambda-1A
  • placebo
  • Botucatu, Brazil
  • +6 more
Jan 17, 2022

Acute Myeloid Leukemia Trial in Ann Arbor (peg-IFN-a, Hematopoietic Cell Transplant (HCT), Tacrolimus)

Completed
Has Results
  • Acute Myeloid Leukemia
  • Ann Arbor, Michigan
    University of Michigan Comprehensive Cancer Center
Oct 1, 2021

Hepatitis Delta Virus Trial in Worldwide (Peginterferon Lambda-1a)

Recruiting
  • Hepatitis Delta Virus
  • Peginterferon Lambda-1a
  • Los Angeles, California
  • +61 more
Jan 30, 2023

Zepatier in Patients With Substance Use

Active, not recruiting
  • Hepatitis C
  • +3 more
  • Elbasvir/Grazoprevir 50 MG-100 MG Oral Tablet [ZEPATIER]
  • Chicago, Illinois
    University of Illinois at Chicago
Jun 28, 2022

Hepatitis C, Chronic Trial in United States (ISIS 14803, peginterferon alfa, ribavirin)

Completed
  • Hepatitis C, Chronic
  • ISIS 14803, peginterferon alfa, ribavirin
  • Birmingham, Alabama
  • +24 more
Dec 1, 2022